FOCAL THERAPY FOR RENAL MASS LESIONS: WHERE DO WE STAND IN 2012?
2012; Wiley; Volume: 109; Issue: 4 Linguagem: Inglês
10.1111/j.1464-410x.2011.10855.x
ISSN1464-410X
AutoresAbhay Rané, Robert J. Stein, Jeffrey A. Cadeddu,
Tópico(s)Pediatric Urology and Nephrology Studies
ResumoBJU InternationalVolume 109, Issue 4 p. 491-492 FOCAL THERAPY FOR RENAL MASS LESIONS: WHERE DO WE STAND IN 2012? Abhay Rane, Corresponding Author Abhay Rane Department of Urology, East Surrey Hospital, Redhill, UKAbhay Rane, East Surrey Hospital, Redhill, RH1 5RH, UK. e-mail: [email protected]Search for more papers by this authorRobert Stein, Robert Stein Cleveland Clinic, Glickman Urologic and Kidney Institute, Cleveland, OHSearch for more papers by this authorJeffrey Cadeddu, Jeffrey Cadeddu Department of Urology, UT South Western, Dallas, TX, USASearch for more papers by this author Abhay Rane, Corresponding Author Abhay Rane Department of Urology, East Surrey Hospital, Redhill, UKAbhay Rane, East Surrey Hospital, Redhill, RH1 5RH, UK. e-mail: [email protected]Search for more papers by this authorRobert Stein, Robert Stein Cleveland Clinic, Glickman Urologic and Kidney Institute, Cleveland, OHSearch for more papers by this authorJeffrey Cadeddu, Jeffrey Cadeddu Department of Urology, UT South Western, Dallas, TX, USASearch for more papers by this author First published: 11 January 2012 https://doi.org/10.1111/j.1464-410X.2011.10855.xCitations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1 Uchida M, Imaide Y, Sugimoto K et al. Percutaneous cryosurgery for renal tumours. Br J Urol 1995; 75: 132–6 10.1111/j.1464-410X.1995.tb07297.x CASPubMedWeb of Science®Google Scholar 2 Aron M, Kamoi K, Remer E, Berger A, Desai M, Gill I. Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol 2010; 183: 889–95 10.1016/j.juro.2009.11.041 PubMedWeb of Science®Google Scholar 3 Mues AC, Okhunov Z, Haramis G, D'Agostino H, Shingleton BW, Landman J. Comparison of percutaneous and laparoscopic renal cryoablation for small (<3.0 cm) renal masses. J Endourol 2010; 24: 1097–100 10.1089/end.2010.0067 PubMedWeb of Science®Google Scholar 4 Sidana A, Aggarwal P, Feng Z, Georgiades CS, Trock BJ, Rodriguez R. Complications of renal cryoablation: a single center experience. J Urol 2010; 184: 42–7 10.1016/j.juro.2010.03.013 PubMedWeb of Science®Google Scholar 5 Rosenberg MD, Kim CY, Tsivian M et al. Percutaneous cryoablation of renal lesions with radiographic ice ball involvement of the renal sinus: analysis of hemorrhagic and collecting system complications. AJR Am J Roentgenol 2011; 196: 935–9 10.2214/AJR.10.5182 PubMedWeb of Science®Google Scholar 6 Zlotta AR, Wildschutz T, Raviv G et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol 1997; 11: 251–8 10.1089/end.1997.11.251 CASPubMedWeb of Science®Google Scholar 7 Gervais DA, McGovern FJ, Arellano RS et al. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185: 64–71 10.2214/ajr.185.1.01850064 PubMedWeb of Science®Google Scholar 8 Levinson AW, Su LM, Agarwal D et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180: 499–504 10.1016/j.juro.2008.04.031 PubMedWeb of Science®Google Scholar 9 Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes following radiofrequency ablation(RFA): experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116: 3135–42 10.1002/cncr.25002 PubMedWeb of Science®Google Scholar 10 Stern J, Svatek R, Park S et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumors. BJU Int 2007; 100: 287–90 10.1111/j.1464-410X.2007.06937.x PubMedWeb of Science®Google Scholar 11 Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative or extirpative techniques. J Urol 2008; 179: 75–9 10.1016/j.juro.2007.08.156 PubMedWeb of Science®Google Scholar Citing Literature Volume109, Issue4February 2012Pages 491-492 ReferencesRelatedInformation
Referência(s)